Niche MRI Uptake Target MRI centers and radiology departments that perform functional imaging and tissue viability assessments, highlighting Oxy-17 and OxyMaps as real-time, non-invasive options for oxygen metabolism imaging and tissue stress monitoring.

InViVo Platform Edge Position the platform as a comprehensive in vivo imaging solution with 1 mm resolution on standard MRI, appealing to biotech labs and clinical researchers seeking actionable oxygen metabolism data without invasive procedures.

IP and Scale Leverage the strong IP position and global coverage for Oxy-17 and related materials to engage larger hospitals and contract research organizations (CROs) that value protected technology and scalable supply.

Software Synergy Pair OxyMaps visualization software with imaging agents to offer end-to-end capabilities for clinicians, researchers, and imaging centers, emphasizing 2D/3D tissue oxygen uptake mapping as a differentiator.

Funding and Growth Capitalize on current revenue and potential expansion opportunities by targeting mid-to-large healthcare systems and academic institutions seeking innovative non-invasive imaging modalities to enhance diagnostic workflows.